Back to Search
Start Over
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study
- Source :
- BMJ Open, BMJ Open, 11(7):e048994. BMJ Publishing Group, BMJ Open, Vol 11, Iss 7 (2021), BMJ Open, 11, BMJ Open, 11(7):048994. BMJ PUBLISHING GROUP, BMJ Open, 11, 7
- Publication Year :
- 2021
-
Abstract
- IntroductionIn patients with myocardial infarction, the decision to treat a nonculprit lesion is generally based on its physiological significance. However, deferral of revascularisation based on nonischaemic fractional flow reserve (FFR) values in these patients results in less favourable outcomes compared with patients with stable coronary artery disease, potentially caused by vulnerable nonculprit lesions. Intravascular optical coherence tomography (OCT) imaging allows for in vivo morphological assessment of plaque ‘vulnerability’ and might aid in the detection of FFR-negative lesions at high risk for recurrent events.Methods and analysisThe PECTUS-obs study is an international multicentre prospective observational study that aims to relate OCT-derived vulnerable plaque characteristics of nonflow limiting, nonculprit lesions to clinical outcome in patients with myocardial infarction. A total of 438 patients presenting with myocardial infarction (ST-elevation myocardial infarction and non-ST-elevation myocardial infarction) will undergo OCT-imaging of any FFR-negative nonculprit lesion for detection of plaque vulnerability. The primary study endpoint is a composite of major adverse cardiovascular events (all-cause mortality, nonfatal myocardial infarction or unplanned revascularisation) at 2-year follow-up. Secondary endpoints will be the same composite at 1-year and 5-year follow-up, target vessel failure, target vessel revascularisation, target lesion failure and target lesion revascularisation.Ethics and disseminationThis study has been approved by the Medical Ethics Committee of the region Arnhem-Nijmegen. The results of this study will be disseminated in a main paper and additional papers with subgroup analyses.Trial registration numberNCT03857971.
- Subjects :
- Target lesion
medicine.medical_treatment
FEATURES
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
Myocardial Infarction
Fractional flow reserve
030204 cardiovascular system & hematology
Cardiovascular Medicine
medicine.disease_cause
Coronary Angiography
ANGIOGRAPHY
Coronary artery disease
0302 clinical medicine
Risk Factors
Intravascular ultrasound
FRACTIONAL FLOW RESERVE
ARTERY-DISEASE
030212 general & internal medicine
Myocardial infarction
Prospective Studies
medicine.diagnostic_test
Vascular damage Radboud Institute for Molecular Life Sciences [Radboudumc 16]
General Medicine
Fractional Flow Reserve, Myocardial
Treatment Outcome
Cardiology
Medicine
coronary intervention
medicine.symptom
INTERVENTION
Tomography, Optical Coherence
PLAQUES
medicine.medical_specialty
Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]
Lesion
03 medical and health sciences
Percutaneous Coronary Intervention
Internal medicine
Angioplasty
medicine
INTRAVASCULAR ULTRASOUND
MANAGEMENT
Humans
coronary heart disease
ANGIOPLASTY
business.industry
ACQUISITION
medicine.disease
Vulnerable plaque
business
Subjects
Details
- ISSN :
- 20446055
- Volume :
- 11
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- BMJ open
- Accession number :
- edsair.doi.dedup.....46f2459e5e6b968b4db9a0ae837f86b7